These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9041476)

  • 21. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3.
    Hostettler ME; Knapp PE; Carlson SL
    Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of tissue injury and altered cardiovascular performance by platelet-activating factor: relevance to multiple systems organ failure.
    Lefer AM
    Crit Care Clin; 1989 Apr; 5(2):331-52. PubMed ID: 2650821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the phospholipase/cyclooxygenase cascade in the rabbit cornea by platelet-activating factor is challenged by PAF receptor antagonists.
    Hurst JS; Bazan HE
    J Ocul Pharmacol Ther; 1995; 11(3):329-37. PubMed ID: 8590265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation.
    Svetlov SI; Howard KM; Miwa M; Flickinger BD; Olson MS
    Arch Biochem Biophys; 1996 Mar; 327(1):113-22. PubMed ID: 8615681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet activating factor as a mediator and therapeutic approach in bronchial asthma.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Inflammation; 2008 Apr; 31(2):112-20. PubMed ID: 18193345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility.
    Delbridge LM; Stewart AG; Goulter CM; Morgan TO; Harris PJ
    J Mol Cell Cardiol; 1994 Feb; 26(2):185-93. PubMed ID: 8006979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of platelet-activating factor release on acute myocardial ischemia in the isolated interventricular septum of rabbit heart.
    Salinas P; Perez MD; Fernandez-Sanpablo R; Fernandez-Gallardo S; Sanchez-Crespo M; Barrigón S
    Eur J Pharmacol; 1995 May; 293(1):65-70. PubMed ID: 7672009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
    Morris DD; Moore JN
    Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
    Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH
    J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arrhythmias caused by platelet activating factor.
    Hoffman BF; Guo SD; Feinmark SJ
    J Cardiovasc Electrophysiol; 1996 Feb; 7(2):120-33. PubMed ID: 8853022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiologic effects of interactions between activated canine neutrophils and cardiac myocytes.
    Hoffman BF; Feinmark SJ; Guo SD
    J Cardiovasc Electrophysiol; 1997 Jun; 8(6):679-87. PubMed ID: 9209969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-activating factor in the CNS.
    Maclennan KM; Smith PF; Darlington CL
    Prog Neurobiol; 1996 Dec; 50(5-6):585-96. PubMed ID: 9015828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species difference in the specific receptors of platelet activating factor.
    Hwang SB; Lam MH
    Biochem Pharmacol; 1986 Dec; 35(24):4511-8. PubMed ID: 3024653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressure.
    Lopes-Martins R; Catelli M; Araújo C; Estato V; Cordeiro R; Tibiriçá E
    Eur J Pharmacol; 1996 Jul; 308(3):287-94. PubMed ID: 8858301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of platelet activating factor (PAF) in physiology and pathology of the central nervous system].
    Farbiszewski R; Dudek H; Skrzydlewska E; Lewko J
    Neurol Neurochir Pol; 2002; 36(4):801-8. PubMed ID: 12418143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-activating factor antagonism: a new concept in the management of regional myocardial ischemia-reperfusion injury.
    Loucks EB; Symersky P; Qayumi AK
    J Invest Surg; 1997; 10(6):321-38. PubMed ID: 9654389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
    Dubois C; Bissonnette E; Rola-Pleszczynski M
    J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of platelet activating factor in immediate heart response to lipopolysaccharide.
    Jakubowski A; Olszanecki R; Chlopicki S
    J Physiol Pharmacol; 2004 Jun; 55(2):409-21. PubMed ID: 15213362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
    Giembycz MA; Kroegel C; Barnes PJ
    J Immunol; 1990 May; 144(9):3489-97. PubMed ID: 2158510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
    Quinn JV; Slotman GJ
    Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.